Valued at USD 6.51 billion in 2025, the global AI in oncology market is projected to reach USD 8.26 billion in 2026 and USD 56.44 billion by 2034, growing at a CAGR of 27.1% during the forecast period 2026–2034. Precision medicine and early cancer detection capabilities are key growth drivers. Major players include Azra AI, IBM, Siemens Healthcare GmbH, Intel Corporation, GE HealthCare,...